ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for LXEO

Stock NameLexeo Therapeutics, Inc. Common Stock
TickerLXEO(USD) NASDAQ
TYPECommon Stock
CountryUSA

Show aggregate LXEO holdings

News associated with LXEO

Brokerages Set Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Target Price at $15.33
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) has been assigned a consensus recommendation of “Buy” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have covered the stock in the last […] - 2025-09-22 02:08:51
Why Lexeo Is Rising In Pre-market?
(RTTNews) - Lexeo Therapeutics (LXEO) announced that the FDA has granted Breakthrough Therapy designation to LX2006 based on clinical evidence generated on both cardiac and neurologic measures of Friedreich ataxia. LX2006 has also been selected to participate in the FDA Chemist - 2025-07-07 08:24:01
HC Wainwright Lowers Lexeo Therapeutics (NASDAQ:LXEO) Price Target to $15.00
Lexeo Therapeutics (NASDAQ:LXEO – Free Report) had its price objective lowered by HC Wainwright from $23.00 to $15.00 in a report released on Friday,Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Lexeo Therapeutics’ Q1 2026 earnings at ($0.62) EPS, Q2 2026 earnings at ($0.63) EPS, […] - 2025-05-19 02:46:49
Brokerages Set Lexeo Therapeutics, Inc. (NASDAQ:LXEO) PT at $22.20
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) has earned a consensus rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month price objective […] - 2025-04-30 02:34:46
Lexeo Therapeutics (NASDAQ:LXEO) Given “Buy” Rating at HC Wainwright
HC Wainwright restated their buy rating on shares of Lexeo Therapeutics (NASDAQ:LXEO – Free Report) in a research report released on Wednesday morning,Benzinga reports. They currently have a $23.00 target price on the stock. A number of other equities research analysts have also commented on LXEO. Leerink Partners decreased their price objective on Lexeo Therapeutics […] - 2025-03-27 06:20:50
Lexeo Therapeutics (NASDAQ:LXEO) Receives Buy Rating from Chardan Capital
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Chardan Capital in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $25.00 target price on the stock. Several other brokerages also recently issued reports on LXEO. Royal Bank of Canada reissued an […] - 2025-03-27 04:01:02
Leerink Partners Has Lowered Expectations for Lexeo Therapeutics (NASDAQ:LXEO) Stock Price
Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) had its price objective dropped by Leerink Partners from $19.00 to $18.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Leerink Partners’ price objective would suggest a potential upside of 305.41% from the stock’s current price. Separately, Royal Bank […] - 2025-03-26 03:48:52
China Universal Asset Management Co. Ltd. Acquires Shares of 7,011 Lexeo Therapeutics, Inc. (NASDAQ:LXEO)
China Universal Asset Management Co. Ltd. acquired a new stake in shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) in the 4th quarter, HoldingsChannel reports. The firm acquired 7,011 shares of the company’s stock, valued at approximately $46,000. Several other institutional investors have also added to or reduced their stakes in the company. BNP […] - 2025-02-04 06:53:06

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) LXEO holdings

DateNumber of LXEO Shares HeldBase Market Value of LXEO SharesLocal Market Value of LXEO SharesChange in LXEO Shares HeldChange in LXEO Base ValueCurrent Price per LXEO Share HeldPrevious Price per LXEO Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LXEO by Blackrock for IE00BYXG2H39

Show aggregate share trades of LXEO

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY2796.4706.690 6.668USD 1,860 4.17
2025-10-03BUY6446.6206.895 6.867USD 4,423 4.16
2025-10-02BUY926.7006.865 6.848USD 630 4.14
2025-09-30BUY1846.6406.710 6.703USD 1,233 4.12
2025-09-26BUY1846.7706.878 6.867USD 1,264 4.09
2025-09-25BUY1846.5006.700 6.680USD 1,229 4.07
2025-09-24BUY12,5486.5407.400 7.314USD 91,776 4.06
2025-09-18BUY545.4605.560 5.550USD 300 4.05
2025-09-17BUY1625.3605.490 5.477USD 887 4.04
2025-09-11SELL-545.1805.300 5.288USD -286 4.02 Loss of -69 on sale
2025-09-10BUY1085.2005.400 5.380USD 581 4.01
2025-09-05SELL-545.0205.280 5.254USD -284 3.99 Loss of -68 on sale
2025-08-29SELL-1624.7904.838 4.833USD -783 3.97 Loss of -140 on sale
2025-08-27BUY1084.8504.960 4.949USD 534 3.96
2025-08-26SELL-544.8904.890 4.890USD -264 3.95 Loss of -51 on sale
2025-08-25BUY544.6605.000 4.966USD 268 3.95
2025-08-20SELL-2164.8004.880 4.872USD -1,052 3.94 Loss of -202 on sale
2025-08-18BUY1084.9204.940 4.938USD 533 3.92
2025-08-08SELL-1084.5304.540 4.539USD -490 3.90 Loss of -69 on sale
2025-08-05BUY544.7304.810 4.802USD 259 3.89
2025-08-01SELL-1624.6104.780 4.763USD -772 3.88 Loss of -144 on sale
2025-07-30BUY2164.6505.059 5.018USD 1,084 3.86
2025-07-17SELL-1084.2604.375 4.364USD -471 3.85 Loss of -55 on sale
2025-07-11SELL-4324.4704.605 4.591USD -1,984 3.84 Loss of -325 on sale
2025-07-07BUY1624.5404.850 4.819USD 781 3.82
2025-07-02BUY2,9704.3804.490 4.479USD 13,303 3.80
2025-06-25BUY1064.1904.495 4.464USD 473 3.79
2025-06-11BUY1064.5104.748 4.724USD 501 3.76
2025-06-10BUY1064.6104.630 4.628USD 491 3.76
2025-06-04SELL-533.1003.180 3.172USD -168 3.76 Profit of 31 on sale
2025-04-23BUY533.3703.730 3.694USD 196 3.97
2025-04-10SELL-4322.1702.349 2.331USD -1,007 4.16 Profit of 792 on sale
2025-04-08SELL-1081.8202.010 1.991USD -215 4.23 Profit of 242 on sale
2025-04-04SELL-2702.3352.680 2.646USD -714 4.30 Profit of 446 on sale
2025-04-01BUY2163.1303.430 3.400USD 734 4.34
2025-03-31SELL-1623.4703.900 3.857USD -625 4.36 Profit of 81 on sale
2025-03-14SELL-8643.0703.220 3.205USD -2,769 4.56 Profit of 1,167 on sale
2025-03-07SELL-1082.7002.950 2.925USD -316 4.76 Profit of 198 on sale
2025-03-04SELL-542.5002.650 2.635USD -142 4.92 Profit of 123 on sale
2025-02-25BUY1083.3753.825 3.780USD 408 5.20
2025-02-19SELL-544.4604.520 4.514USD -244 5.35 Profit of 45 on sale
2025-02-13BUY1624.2204.290 4.283USD 694 5.50
2025-02-12BUY543.9504.270 4.238USD 229 5.56
2025-02-11BUY2164.2504.910 4.844USD 1,046 5.61
2025-01-17BUY2165.0705.290 5.268USD 1,138 6.19
2025-01-16BUY2165.1905.730 5.676USD 1,226 6.33
2025-01-10SELL-1086.3906.710 6.678USD -721 6.77 Profit of 10 on sale
2025-01-08SELL-2166.8207.250 7.207USD -1,557 6.67 Loss of -116 on sale
2025-01-02BUY1,4526.6706.990 6.958USD 10,103 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LXEO

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1962,0870153,92240.3%
2025-09-1861,5980153,18340.2%
2025-09-1741,1260129,83231.7%
2025-09-16106,5030160,11566.5%
2025-09-1572,747500210,93034.5%
2025-09-12103,1810997,03610.3%
2025-09-1170,1260100,62069.7%
2025-09-10582,2360609,47695.5%
2025-09-09146,1590174,88183.6%
2025-09-0873,8820130,39356.7%
2025-09-0573,1550229,65531.9%
2025-09-0434,4880201,58517.1%
2025-09-0353,4990147,73436.2%
2025-09-0255,5684,70086,36864.3%
2025-08-2944,40698862,35871.2%
2025-08-2840,437072,92355.5%
2025-08-2747,237077,78760.7%
2025-08-2664,8480115,31356.2%
2025-08-2568,6840132,90451.7%
2025-08-2244,0200168,02126.2%
2025-08-2155,8393145,34638.4%
2025-08-2056,7080106,17053.4%
2025-08-1991,4821148,02661.8%
2025-08-1875,1370153,06349.1%
2025-08-15140,1130265,72652.7%
2025-08-1453,9750158,12634.1%
2025-08-1333,592077,78543.2%
2025-08-1221,622056,68638.1%
2025-08-1150,487082,01461.6%
2025-08-0838,316084,95145.1%
2025-08-0746,09088488,79651.9%
2025-08-0661,490086,89270.8%
2025-08-0540,6822570,37557.8%
2025-08-0451,6533,090113,15945.6%
2025-08-0194,5840166,33356.9%
2025-07-31126,3021,129269,70946.8%
2025-07-30289,4240624,64246.3%
2025-07-2952,356091,39357.3%
2025-07-2887,7710189,33446.4%
2025-07-25117,4330177,45566.2%
2025-07-2477,4250135,99456.9%
2025-07-2393,0620200,30246.5%
2025-07-2252,57010110,13347.7%
2025-07-21131,697116244,16353.9%
2025-07-1840,557096,52742.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy